Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade

Transplantation

Volumn 65, Issue 11, 1998, Pages 1422-1428

  Elwood, Eric T ^a   Larsen, Christian P ^a,d   Cho, Hong Rae ^a   Corbascio, Matthias ^b   Ritchie, Shannon C ^a   Alexander, Diane Z ^a   Tucker Burden, Carol ^a   Linsley, Peter S ^c,e   Aruffo, Alejandro ^c   Hollenbaugh, Diane ^c   Winn, Kevin J ^a   Pearson, Thomas C ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BRISTOL MYERS SQUIBB   (United States)

^d EMORY UNIVERSITY   (United States)

^e ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN GRAFT; SPECIES DIFFERENCE; SWINE; T LYMPHOCYTE ACTIVATION; WHOLE BODY RADIATION; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, DIFFERENTIATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED DBA; RATS; RATS, SPRAGUE-DAWLEY; SKIN TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032526076     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806150-00002     Document Type: Article

References (30)

1. Platt JL. Xenotransplantation: recent progress and current perspective. Curr Opin Immunol 1996; 8: 721.
2. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
3. + T cells. J Exp Med 1989; 170: 991.
4. Sharabi Y, Aksentijevich I, Sundt TM III, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barner: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
5. Zhao Y, Swenson K, Sergio JJ, Arn JS, Sachs DH, Sykes M. Skin graft tolerance across a discordant xenogeneic barrier [see comments]. Nat Med 1996; 2: 1211.
6. Jenkins MK, Taylor PS, Norton SD, Urdahl KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991; 147: 2461.
7. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993; 178: 1753.
8. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71: 1065.
9. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80.
10. 4+ T lymphocytes. J Immunol 1994; 152: 1523.
11. Hollenbaugh D, Mischel-Petty N, Edwards CP, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33.
12. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378: 617.
13. Grewal IS, Foellmer HG, Grewal KD, et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996; 273: 1864.
14. Noelle R, Roy M, Shepherd D, Stamenkovic I, Ledbetter J, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89: 6550.
15. Alderson M, Armitage R, Tough T, Strockbine L, Fanslow W, Spriggs M. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669.
16. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
17. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 1996; 61: 4.
18. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 9560.
19. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
20. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non H-2 antigens in rejection. Transplantation 1973; 16: 343.
21. 4+ helper cells. J Exp Med 1990; 171: 1315.
22. Pearson TC, Alexander DZ, Corbascio M, et al. Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 1997; 63: 1463.
23. Aksentijevich I, Sachs DH, Sykes M. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen. Transplantation 1992; 53: 1108.
24. Leventhal JR, Matas AJ, Sun LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1.
25. Sachs DH, Sykes M, Greenstein JL, Cosimi AB. Tolerance and xenograft survival. Nat Med 1995; 1: 969.
26. Lenschow D, Zeng Y, Thistlethwaite J, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
27. Mayumi H, Himeno K, Tanaka K, Tokuda N, Fan J-L, Nomoto K. Drug-induced tolerance to allografts in mice. XII. The relationships between tolerance, chimerism, and graft-versus-host disease. Transplantation 1987; 44: 286.
28. Qin S, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
29. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323: 164.
30. Cotterell AH, Collins BH, Parker W, Harland RC, Platt JL. The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 1995; 60: 861.